Top Markets
Coin of the day
Zynerba Pharmaceuticals, Inc. Zynerba Pharmaceuticals, Inc.

Zynerba Pharmaceuticals, Inc.

ZYNE
Rankning i aktier #26763
Zynerba Pharmaceuticals, Inc. is a specialized pharmaceutical firm currently in... Zynerba Pharmaceuticals, Inc. is a specialized pharmaceutical firm currently in the clinical development phase. Its primary objective is to create and advance medicinal transdermal cannabinoid treatments specifically for uncommon and scarcely encountered neuropsychiatric conditions. A key product in its pipeline is Zygel, a pharmaceutical-grade cannabidiol expertly crafted into a gel with enhanced skin penetration for topical application. Originally established as AllTranz, Inc., the company adopted its current name, Zynerba Pharmaceuticals, Inc., in August 2014. Founded in 2007, Zynerba Pharmaceuticals maintains its headquarters in Devon, Pennsylvania.
Aktiekurs
$1.30
Senast synkroniserad: 2023-10-13
Marknadsvärde
$38.02M
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
US
Handel Zynerba Pharmaceuticals, Inc. (ZYNE)

Kategori

Aktiekurshistorik för Zynerba Pharmaceuticals, Inc. (ZYNE)
Högsta slutkurs: $1.27 den 2023-10-01

Lägsta slutkurs: $28.18 den 2015-08-01
Aktiekurshistorik för Zynerba Pharmaceuticals, Inc. från 2015 till 2026
Årlig aktiekursutveckling
År Prestanda
2023 121.20%
2022 -82.15%
2021 -16.92%
2020 -34.43%
2019 51.25%
2018 -67.91%
2017 -17.16%
2016 20.03%
2015 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$171.67 -
DE
$162.44 24.86%
DE
$38.00 22.72%
JP
$221.55 33.82%
CH
$21.01 11.96%
IN